Baum, Richard P.;
Zhang, Jingjing;
Schuchardt, Christiane;
Müller, Dirk;
Mäcke, Helmut
First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy
Contributor:
Baum, Richard P.;
Zhang, Jingjing;
Schuchardt, Christiane;
Müller, Dirk;
Mäcke, Helmut
imprint:
Society of Nuclear Medicine, 2021
Published in:
Journal of Nuclear Medicine, 62 (2021) 11, Seite 1571-1581